CD4 and cancer: Notably, although most of the tumours raised in HIV patients seem to be a secondary event of reduced antiviral immunity, CD4+ T-cell counts in peripheral blood of HIV-infected individuals inversely correlate with increased cancer risk also for tumours unrelated to viral infections, thus supporting the association between tumour onset and immunosuppression.